NBY NovaBay Pharmaceuticals, Inc.: שווי נכסים נקי

NovaBay Pharmaceuticals (NBY) is expanding sales of Avenova products, focusing on online channels and increasing its presence in clinics. Patent protection of chemical formulas and strict regulatory oversight create significant barriers to entry for competitors. The price indicator on the chart, with a value of -0.06, confirms the business's resilience to crises, where success depends on medical test results and the implementation of new drugs.

By delegating distribution to third-party operators, NovaBay Pharmaceuticals (NBY) optimizes costs, which directly impacts the dynamics of its book value. This indicator captures the difference between all of the issuer's assets and liabilities, allowing investors to strip away market volatility from actual changes in net asset value and objectively assess the fundamental stability of the company's capital.